Open AccessUse of new technologies in pregnancy
Author(s) -
I. Ragusa
Publication year - 2019
Publication title -
j. amd
Language(s) - English
Resource type - Journals
ISSN - 2532-4799
DOI - 10.36171/jamd19.22.3.09
Subject(s) - pregnancy , medicine , continuous glucose monitoring , diabetes in pregnancy , diabetes mellitus , fetus , intensive care medicine , type 1 diabetes , insulin , obstetrics , gestation , endocrinology , gestational diabetes , genetics , biology
Diabetes in pregnancy is associated with an increased risk of maternal and neonatal complications. Several trials have showed that adequate pregnancy planning and optimal glucose control are essential to reduce the risk of fetal malformations and to improve maternal-fetal outcomes. In clinical practice it’s hard to reach an optimal glucose control in pregnancy. Thus, the new technologies designed to assist patient with diabetes (Continuous subcutaneous insulin infusion and/or Continuous Glucose Monitoring) are widely used during pregnancy planning and management. This article discusses the use of new technologies in the management of diabetes during pregnancy and their effects on glicemic control and maternal-fetal outcomes KEY WORDS diabetes in pregnancy; continuous subcutaneous insulin infusion; continuous glucose monitoring; efficacy; safety